ABCG2 and cancer: By using various in vitro cellular and membrane vesicular assays, we have shown that some of the primaquine fumardiamides have potent inhibitory effects on ABCG2 and can sensitize cancer cell lines to the chemotherapeutic agent mitoxantrone.